{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:57:12Z","timestamp":1756810632521,"version":"3.40.5"},"reference-count":29,"publisher":"Sociedade Brasileira de Cardiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,21]]},"DOI":"10.36660\/abc.20200492","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T14:53:07Z","timestamp":1621867987000},"source":"Crossref","is-referenced-by-count":2,"title":["Associa\u00e7\u00e3o entre os N\u00edveis S\u00e9ricos de Elabela e Oclus\u00e3o Total Cr\u00f4nica em Pacientes com Angina Pectoris Est\u00e1vel"],"prefix":"10.36660","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1913-4212","authenticated-orcid":false,"given":"Fethi","family":"Yavuz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7081-5799","authenticated-orcid":false,"given":"Mehmet","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"1","key":"key20210524105252_B1","first-page":"84","article-title":"European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions","volume":"4","author":"Sianos","year":"2008","unstructured":"1. Sianos G, Barlis P, Di Mario C, Papafaklis MI, Buttner J, Galassi AR, et al. European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the euroCTO club. EuroIntervention. 2008;4(1):84-92.","journal-title":"A report on behalf of the euroCTO club. EuroIntervention"},{"issue":"9","key":"key20210524105252_B2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.amjcard.2004.12.065","article-title":"Effect of chronic total coronary occlusion on treatment strategy","volume":"95","author":"Christofferson","year":"2005","unstructured":"2. Christofferson RD, Lehmann KG, Martin GV, Every N, Caldwell JH, Kapadia SR. Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol. 2005;95(9):1088-91.","journal-title":"Am J Cardiol"},{"issue":"9","key":"key20210524105252_B3","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1002\/jcp.26492","article-title":"Biological functions of Elabela, a novel endogenous ligand of APJ receptor","volume":"233","author":"Xu","year":"2018","unstructured":"3. Xu J, Chen L, Jiang Z, Li L. Biological functions of Elabela, a novel endogenous ligand of APJ receptor. J Cell Physiol. 2018;233(9):6472-82.","journal-title":"J Cell Physiol"},{"key":"key20210524105252_B4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.peptides.2018.09.006","article-title":"Elabela, a newly discovered APJ ligand: Similarities and differences with Apelin","volume":"109","author":"Zhang","year":"2018","unstructured":"4. Zhang Y, Wang Y, Lou Y, Luo M, Lu Y, Li Z, et al. Elabela, a newly discovered APJ ligand: Similarities and differences with Apelin. Peptides. 2018;109:23-32.","journal-title":"Peptides"},{"issue":"1","key":"key20210524105252_B5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cphy.c170028","article-title":"Apelinergic system structure and function","volume":"8","author":"Shin","year":"2017","unstructured":"5. Shin K, Kenward C, Rainey JK. Apelinergic system structure and function. Comp Physiol. 2017;8(1):407\u201350.","journal-title":"Comp Physiol"},{"key":"key20210524105252_B6","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1038\/srep08170","article-title":"Elabela-apelin receptor signaling pathway is functional in mammalian systems","volume":"5","author":"Wang","year":"2015","unstructured":"6. Wang Z, Yu D, Wang M, Wang Q, Kouznetsova J, Yang R, et al. Elabela-apelin receptor signaling pathway is functional in mammalian systems. Sci Rep. 2015;5:8170.","journal-title":"Sci Rep"},{"issue":"1","key":"key20210524105252_B7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ydbio.2006.04.452","article-title":"Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo","volume":"296","author":"Cox","year":"2006","unstructured":"7. Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol. 2006;296(1):177-89.","journal-title":"Dev Biol"},{"issue":"7","key":"key20210524105252_B8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/cvr\/cvx061","article-title":"ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage","volume":"113","author":"Sato","year":"2017","unstructured":"8. Sato T, Sato C, Kadowaki A, Watanabe H, Ho L, Ishida J, et al. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage. Cardiovasc Res. 2017;113(7):760-9.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"key20210524105252_B9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.stem.2015.08.010","article-title":"ELABELA is an endogenous growth factor that sustains hESC self-renewal via the PI3K\/AKT pathway","volume":"17","author":"Ho","year":"2015","unstructured":"9. Ho L, Tan SY, Wee S, Wu Y, Tan SJ, Ramakrishna NB, et al. ELABELA is an endogenous growth factor that sustains hESC self-renewal via the PI3K\/AKT pathway. Cell Stem Cell. 2015;17(4):435-47.","journal-title":"Cell Stem Cell"},{"issue":"9","key":"key20210524105252_B10","first-page":"2694","article-title":"ELABELA and an ELABELA fragment protect against AKI","volume":"28","author":"Chen","year":"2017","unstructured":"10. Chen H, Wang L, Wang W, Cheng C, Zhang Y, Zhou Y, et al. ELABELA and an ELABELA fragment protect against AKI. J Am SocNephrol. 2017;28(9):2694-707.","journal-title":"J Am SocNephrol"},{"issue":"5","key":"key20210524105252_B11","doi-asserted-by":"crossref","first-page":"E773","DOI":"10.1152\/ajpendo.00383.2018","article-title":"ELABELA, as a potential diagnostic biomarker of pre-eclampsia, regulates abnormally shallow placentation via APJ","volume":"316","author":"Zhou","year":"2019","unstructured":"11. Zhou L, Sun H, Cheng R, Fan X, Lai S, Deng C. ELABELA, as a potential diagnostic biomarker of pre-eclampsia, regulates abnormally shallow placentation via APJ. Am J Physiol Endocrinol Metab. 2019; 316(5):E773-81.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"key20210524105252_B12","first-page":"1347","article-title":"Serum Elabela\/Toddler Levels Are Associated with Albuminuria in Patients with Type 2 Diabetes","volume":"48","author":"Zhang","year":"2018","unstructured":"12. Zhang H, Gong D, Ni L, Shi L, Xu W, Shi M, et al. Serum Elabela\/Toddler Levels Are Associated with Albuminuria in Patients with Type 2 Diabetes. Cell PhysiolBiochem. 2018; 48(3):1347-54.","journal-title":"Cell PhysiolBiochem"},{"issue":"3","key":"key20210524105252_B13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0735-1097(85)80380-6","article-title":"Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects","volume":"5","author":"Rentrop","year":"1985","unstructured":"13. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985;5(3):587\u201392.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"key20210524105252_B14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00019501-200205000-00004","article-title":"Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion","volume":"13","author":"ilian","year":"2002","unstructured":"14. ilian JG, Keech A, Adams MR, Celermajer DS. Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coron Artery Dis. 2002;13(3):155\u20139.","journal-title":"Coron Artery Dis"},{"issue":"2","key":"key20210524105252_B15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","unstructured":"15. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251(2):471-6.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"key20210524105252_B16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00395-007-0671-2","article-title":"Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury","volume":"102","author":"Simpkin","year":"2007","unstructured":"16. Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Res Cardiol. 2007;102(6):518\u201328.","journal-title":"Basic Res Cardiol"},{"issue":"1-3","key":"key20210524105252_B17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2006.09.034","article-title":"Apelin increases contractility in failing cardiac muscle","volume":"553","author":"Dai","year":"2006","unstructured":"17. Dai T, Ramirez-Correa G, Gao WD. Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol. 2006;553(1-3):222\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"key20210524105252_B18","doi-asserted-by":"crossref","first-page":"H2007","DOI":"10.1152\/ajpheart.00089.2009","article-title":"Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension","volume":"296","author":"Falc\u00e3o-Pires","year":"2009","unstructured":"18. Falc\u00e3o-Pires I, Gon\u00e7alves N, Henriques-Coelho T, Gon\u00e7alves DM, Albuquerque Jr RR, Moreira AF. Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009;296(6):H2007\u201314.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"key20210524105252_B19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","unstructured":"19. Chng SC, Ho L, Tian J, Reversade B. ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell 2013;27(6):672-80.","journal-title":"Dev Cell"},{"issue":"6172","key":"key20210524105252_B20","doi-asserted-by":"crossref","DOI":"10.1126\/science.1248636","article-title":"Toddler: an embryonic signal that promotes cell movement via Apelin receptors","volume":"343","author":"Pauli","year":"2014","unstructured":"20. Pauli A, Norris ML, Valen E, Chew GL, Gagnon JA, Zimmerman S, et al. Toddler: an embryonic signal that promotes cell movement via Apelin receptors. Science (New York, NY). 2014;343(6172):1248636.","journal-title":"Science (New York, NY)"},{"issue":"22","key":"key20210524105252_B21","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2169\/internalmedicine.47.1287","article-title":"Reduced apelin levels in stable angina","volume":"47","author":"Li","year":"2008","unstructured":"21. Li Z, Bai Y, Hu J. Reduced apelin levels in stable angina. Intern Med, 2008; 47(22):1951\u20135.","journal-title":"Intern Med"},{"issue":"6","key":"key20210524105252_B22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/eurjhf\/hfp043","article-title":"Plasma apelin concentration is depressed following acute myocardial infarction in man","volume":"11","author":"Weir","year":"2009","unstructured":"22. Weir RA, Chong KS, Dalzell JR, Petrie CJ, Murphy CA, Steedman T, et al. Plasma apelin concentration is depressed following acute myocardial infarction in man. Eur J Heart Fail. 2009;11(6):551\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"key20210524105252_B23","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/abbs\/gmx098","article-title":"Elabela-APJ axis: a novel therapy target for cardiovascular diseases","volume":"49","author":"Li","year":"2017","unstructured":"23. Li L, Zhou Q, Li X, Chen L. Elabela-APJ axis: a novel therapy target for cardiovascular diseases. Acta Biochim Biophys Sin (Shanghai). 2017;49(11):1042-3.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"9","key":"key20210524105252_B24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/res.89.9.747","article-title":"The putative convergent and divergent natures of angiogenesis and arteriogenesis","volume":"89","author":"Lindner","year":"2001","unstructured":"24. Lindner V, Maciag T. The putative convergent and divergent natures of angiogenesis and arteriogenesis. Circ Res. 2001; 89(9):747-9.","journal-title":"Circ Res"},{"key":"key20210524105252_B25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06726","article-title":"The hormonal peptide Elabela guides angioblasts to the midline during vasculogenesis","volume":"4","author":"Helker","year":"2015","unstructured":"25. Helker CS, Schuermann A, Pollmann C, Chng SC, Kiefer F, Reversade B, et al. The hormonal peptide Elabela guides angioblasts to the midline during vasculogenesis. eLife. 2015;4:e06726.","journal-title":"eLife"},{"issue":"6","key":"key20210524105252_B26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.devcel.2017.08.008","article-title":"Alternative Progenitor Cells Compensate to Rebuild the Coronary Vasculature in Elabela- and Apj-Deficient Hearts","volume":"42","author":"Sharma","unstructured":"26. Sharma B, Ho L, Ford GH, Chen HI, Goldstone AB, Woo YJ, et al. Alternative Progenitor Cells Compensate to Rebuild the Coronary Vasculature in Elabela- and Apj-Deficient Hearts. Dev Cell. 42(6):655-66.e3.","journal-title":"Dev Cell"},{"issue":"1","key":"key20210524105252_B27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00395-015-0521-6","article-title":"Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart","volume":"111","author":"Perj\u00e9s","year":"2016","unstructured":"27. Perj\u00e9s \u00c1, Kilpi\u00f6 T, Ulvila J, Magga J, Alakoski T, Szab\u00f3 Z, et al. Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart. Basic Res Cardiol. 2016;111(1): 2.","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"key20210524105252_B28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ejheart.2005.10.007","article-title":"Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure","volume":"8","author":"Chong","unstructured":"28. Chong KS, Gardner RS, Morton JJ, Ashley EA, McDonagh TA. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. Eur J Heart Fail. 8(4):355\u201360.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"key20210524105252_B29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.yjmcc.2006.07.004","article-title":"Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system","volume":"41","author":"Iwanaga","unstructured":"29. Iwanaga Y, Kihara Y, Takenaka H, Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol. 41(5):798\u2013806.","journal-title":"J Mol Cell Cardiol"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/associacao-entre-os-niveis-sericos-de-elabela-e-oclusao-total-cronica-em-pacientes-com-angina-pectoris-estavel\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:04:35Z","timestamp":1747400675000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/associacao-entre-os-niveis-sericos-de-elabela-e-oclusao-total-cronica-em-pacientes-com-angina-pectoris-estavel\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":29,"alternative-id":["10.36660\/abc.20200492"],"URL":"https:\/\/doi.org\/10.36660\/abc.20200492","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"type":"print","value":"0066-782X"},{"type":"electronic","value":"1678-4170"}],"subject":[],"published":{"date-parts":[[2021,5,21]]}}}